Table 2 Overall ureteral stent in situ-related symptoms

Urinary symptoms

Domain total

30.6

28.2

8.54

7.25

0.17*

Daytime frequency

3.02

3.37

1.14

1.25

0.17*

Nocturia

2.58

2.40

1.07

1.30

0.48*

Urgency

2.21

1.97

1.01

1.11

0.31*

Urge incontinence

1.42

1.33

0.63

0.82

0.59*

Non urge incontinence

1.37

1.16

0.72

0.63

0.14*

Residual urine sensation

3.02

2.60

1.18

1.29

0.11*

Dysuria

2.95

2.36

1.53

1.05

0.03*

Hematuria frequency

3.12

2.80

1.61

1.27

0.31*

Hematuria amount

2.32

2.29

1.06

0.87

0.86*

Interference in life

2.81

2.44

1.31

1.12

0.16*

Quality of life impact

5.76

5.51

1.50

1.31

0.40*

Pain

Domain total

21.02

20.40

6.39

5.38

0.62*

Presence or absence of pain

1.23

1.16

0.43

0.37

0.39*

VAS

6.27

5.71

2.84

2.90

0.36*

Pain associated with amount of physical activities

3.20

3.02

1.25

1.32

0.50*

Sleep disturbance

2.20

2.13

1.10

1.04

0.74*

Pain at voiding

3.33

3.09

1.24

1.04

0.34*

Flank pain at voiding

1.37

1.47

0.49

0.50

0.37*

Frequency of painkiller

2.16

2

1.13

0.93

0.46*

Overall bother

3.05

2.84

1.31

1.04

0.42*

General health

Domain total

15.12

14.04

5.97

5.09

0.37*

Difficulties with light physical activity

2.23

1.91

1.36

0.99

0.20*

Difficulties with heavy physical activity

2.77

2.18

1.46

1.21

0.04*

Feeling tired

2.33

2.4

1.21

1.18

0.77*

Feeling calm and peaceful

3.40

3.53

1.43

1.42

0.65*

Social life enjoyment

2.88

2.62

1.33

1.34

0.36*

Need extra help

1.51

1.4

0.91

0.86

0.56*

Work performance

Domain total

14.41

15.6

6.32

7.04

0.41*

Type of employment

2.30

3.31

2.22

2.65

0.06*

Number of days bed rest all day long

1.79

1.47

2.73

2.30

0.55*

Number of days reduced more than half daily activity

1.80

2.24

1.80

2.64

0.30*

Position or role in workplace

1.81

1.75

0.93

0.84

0.74*

Frequency of rest

1.98

1.08

2.44

1.22

0.06*

Stent related changes on work

2.28

1.98

1.22

1.05

0.22*

Changes in work duration

2.51

2.44

1.45

1.27

0.82*

Sexual matters

No active sexual life: n (%)

42(97.6)

38(82.6)

-

-

0.02**

Stop of sexual Intercourse after stent: n (%)

22(52)

18(47.3)

-

-

0.82**

Stop of sexual intercourse due to stent-related problem: n (%)

17(77)

8(44.4)

-

-

0.03**

Additional problems

Need for additional antibiotics (%)

0

0

-

-

-

Admission or additional therapeutic procedure(%)

0

0

-

-

-